查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969880

全球水產養殖疫苗市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Aquaculture Vaccines Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 174 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計水產養殖疫苗市場將從 2025 年的 4.5364 億美元成長到 2034 年的 9.4298 億美元，2026 年至 2034 年的複合年成長率為 8.47%。

隨著水產養殖在全球日益重要，全球水產養殖疫苗市場正迅速成長。由於水產品需求增加和野生魚類資源減少，水產養殖產量顯著擴大。這種成長加劇了魚貝類疾病預防的必要性。疫苗在現代水產養殖實踐中至關重要，因為它們有助於降低死亡率、提高產量並確保更高品質的水產品。

市場的主要促進因素包括人們對魚類健康管理意識的提高以及水產養殖中抗生素使用監管的日益嚴格。政府和環保組織積極推廣永續水產養殖實踐，也推動了疫苗的普及。疫苗研發技術的進步，例如口服疫苗和浸泡疫苗，使得全球水產養殖戶能夠更輕鬆、更經濟地預防疾病。

未來幾年，由於亞太地區、歐洲和南美洲水產養殖場的持續創新和擴張，預計市場將迎來強勁成長。對研發和生物技術投入的增加將有助於開發更有效、更具物種特異性的疫苗。隨著全球水產品需求的持續成長，水產養殖疫苗市場將在確保安全永續的魚類生產方面發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球水產養殖疫苗市場：依疫苗類型分類

  • 市場分析、洞察與預測
  • 去活化疫苗
  • 減毒活疫苗
  • 次單位疫苗
  • 其他疫苗類型

第5章：全球水產養殖疫苗市場：依給藥途徑分類

  • 市場分析、洞察與預測
  • 注射疫苗
  • 浸沒和噴淋
  • 口服疫苗

第6章 全球水產養殖疫苗市場：依應用領域分類

  • 市場分析、洞察與預測
  • 細菌
  • 病毒性的
  • 寄生
  • 合成的

第7章 全球水產養殖疫苗市場：依類型分類

  • 市場分析、洞察與預測
  • 鮭魚
  • 鱒魚
  • 吳郭魚
  • 鱸魚
  • 泰國
  • 比目魚
  • 鯉魚
  • 其他物種

第8章 全球水產養殖疫苗市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • CIBA
    • Hipra
    • Kyoto Biken Laboratories
    • Kemin Industries
    • Kyoritsuseiyaku Corporation
    • Merck Animal Health（Merck & Co.）
    • Nisseiken
    • Phibro Animal Health Corporation
    • Tecnovax
    • Virbac
    • Veterquimica
    • Vaxxinova International
    • Zoetis
簡介目錄
Product Code: VMR112110574

The Aquaculture Vaccines Market size is expected to reach USD 942.98 Million in 2034 from USD 453.64 Million (2025) growing at a CAGR of 8.47% during 2026-2034.

The Global Aquaculture Vaccines Market is growing rapidly as fish farming becomes more important worldwide. With the increasing demand for seafood and the decline of wild fish stocks, aquaculture production is expanding significantly. This growth has increased the need for disease prevention in fish and shellfish farming. Vaccines help reduce mortality rates, improve productivity, and ensure better quality seafood, making them essential in modern aquaculture practices.

Key drivers of the market include the rising awareness about fish health management and the strict regulations on antibiotic use in aquaculture. Governments and environmental agencies are encouraging sustainable farming methods, which boosts vaccine adoption. Technological advancements in vaccine development, such as oral and immersion vaccines, are also making disease prevention easier and more cost-effective for farmers around the world.

In the coming years, the market is expected to witness strong growth due to continuous innovation and expansion of aquaculture farms in Asia-Pacific, Europe, and South America. Increasing investments in research and biotechnology will lead to more effective and species-specific vaccines. As global seafood demand continues to rise, the Aquaculture Vaccines Market is likely to play a vital role in ensuring safe and sustainable fish production.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Vaccine Type

  • Inactivated Vaccine
  • Live Attenuated Vaccine
  • Subunit Vaccine
  • Other Vaccine Types

By Route of Administration

  • Injection Vaccines
  • Immersion And Spray
  • Oral Vaccines

By Application

  • Bacterial
  • Viral
  • Parasitic
  • Combined

By Species

  • Salmon
  • Trout
  • Tilapia
  • Seabass
  • Seabream
  • Turbot
  • Carp
  • Other species

COMPANIES PROFILED

  • CIBA, Hipra, Kyoto Biken Laboratories, Kemin Industries, Kyoritsuseiyaku Corporation, Merck Animal Health Merck Co, Nisseiken, Phibro Animal Health Corporation, Tecnovax, Virbac, Veterquimica, Vaxxinova International, Zoetis
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AQUACULTURE VACCINES MARKET: BY VACCINE TYPE 2022-2034 (USD MN and Million Doses)

  • 4.1. Market Analysis, Insights and Forecast Vaccine Type
  • 4.2. Inactivated Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.3. Live Attenuated Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.4. Subunit Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 4.5. Other Vaccine Types Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL AQUACULTURE VACCINES MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN and Million Doses)

  • 5.1. Market Analysis, Insights and Forecast Route Of Administration
  • 5.2. Injection Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.3. Immersion And Spray Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 5.4. Oral Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL AQUACULTURE VACCINES MARKET: BY APPLICATION 2022-2034 (USD MN and Million Doses)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Bacterial Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.3. Viral Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.4. Parasitic Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 6.5. Combined Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL AQUACULTURE VACCINES MARKET: BY SPECIES 2022-2034 (USD MN and Million Doses)

  • 7.1. Market Analysis, Insights and Forecast Species
  • 7.2. Salmon Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.3. Trout Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.4. Tilapia Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.5. Seabass Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.6. Seabream Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.7. Turbot Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.8. Carp Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
  • 7.9. Other species Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 8. GLOBAL AQUACULTURE VACCINES MARKET: BY REGION 2022-2034(USD MN and Million Doses)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.2.1 By Vaccine Type
    • 8.2.2 By Route Of Administration
    • 8.2.3 By Application
    • 8.2.4 By Species
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.3.1 By Vaccine Type
    • 8.3.2 By Route Of Administration
    • 8.3.3 By Application
    • 8.3.4 By Species
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.4.1 By Vaccine Type
    • 8.4.2 By Route Of Administration
    • 8.4.3 By Application
    • 8.4.4 By Species
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.5.1 By Vaccine Type
    • 8.5.2 By Route Of Administration
    • 8.5.3 By Application
    • 8.5.4 By Species
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
    • 8.6.1 By Vaccine Type
    • 8.6.2 By Route Of Administration
    • 8.6.3 By Application
    • 8.6.4 By Species
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL AQUACULTURE VACCINES INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 CIBA
    • 10.2.2 Hipra
    • 10.2.3 Kyoto Biken Laboratories
    • 10.2.4 Kemin Industries
    • 10.2.5 Kyoritsuseiyaku Corporation
    • 10.2.6 Merck Animal Health (Merck & Co.)
    • 10.2.7 Nisseiken
    • 10.2.8 Phibro Animal Health Corporation
    • 10.2.9 Tecnovax
    • 10.2.10 Virbac
    • 10.2.11 Veterquimica
    • 10.2.12 Vaxxinova International
    • 10.2.13 Zoetis